Classification of transient epileptic amnesia attacks: Two types of amnestic seizures, the pure amnesia type and partial amnesia type.
accelerated long‐term forgetting
classification
pure amnesia
topographical amnesia
transient epileptic amnesia
Journal
PCN reports : psychiatry and clinical neurosciences
ISSN: 2769-2558
Titre abrégé: PCN Rep
Pays: Australia
ID NLM: 9918451287106676
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
30
03
2023
revised:
21
05
2023
accepted:
05
06
2023
medline:
13
6
2024
pubmed:
13
6
2024
entrez:
13
6
2024
Statut:
epublish
Résumé
Transient epileptic amnesia (TEA) is a type of mesial temporal lobe epilepsy characterized by recurrent amnesia attacks. In 1998, Zeman et al. proposed the following diagnostic criteria for TEA: (1) recurrent, witnessed episodes of amnesia (TEA attacks); (2) other cognitive functions remain intact during attacks; and (3) evidence of epilepsy. It was also reported that patients with TEA often demonstrate two other types of memory symptoms: accelerated long-term forgetting (ALF) and autobiographical amnesia (AbA). Both ALF and AbA are persistent memory disorders, but transient epileptic seizures are not. We encountered two cases of TEA associated with two types of amnesia attacks. Therefore, we reviewed TEA cases in the literature to clarify the type of TEA attacks that occurred. Based on the extracted TEA cases, including our two cases, we found that there are two main types of TEA attacks, and we discussed their clinical features. We propose two main types of TEA attacks; that is, pure amnesia-type and partial amnesia-type seizures. Furthermore, we also propose that topographical amnesia mainly manifests as a type of amnesia attack, rather than as a chronic memory disturbance, such as ALF or AbA.
Identifiants
pubmed: 38868152
doi: 10.1002/pcn5.114
pii: PCN5114
pmc: PMC11114409
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e114Informations de copyright
© 2023 The Authors. Psychiatry and Clinical Neurosciences Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. Dr. Ukai received speaker's honoraria from Daiichi Sankyo in 2022. Dr. Ito has received speaker's honoraria from Nippon Chemiphar, Eisai, and UCB Japan. Dr. Watanabe has received speaker's honoraria from Otsuka, Eisai, Daiichi Sankyo, and UCB Japan. No grants or other sources of funding were received for this study.